Crx-103, A Novel Duocarmycin-Analog Tumor-Activated Prodrug Demonstrates Superior Efficacy In A Multidrug-Resistant Human Tumor Xenograft Model.

C Pan,F Zhou, A Salles, H Lee,G Wu, O Saunders,C Bebbington,G Yarranton,H Ng, L Pickford

CLINICAL CANCER RESEARCH（2001）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined